Risk of malignancies in patients with diabetes treated with human insulin or insulin analogues: a cohort study
Top Cited Papers
Open Access
- 30 June 2009
- journal article
- research article
- Published by Springer Nature in Diabetologia
- Vol. 52 (9), 1732-1744
- https://doi.org/10.1007/s00125-009-1418-4
Abstract
The aim of this cohort study was to investigate the risk of malignant neoplasms and mortality in patients with diabetes treated either with human insulin or with one of three insulin analogues.Keywords
This publication has 23 references indexed in Scilit:
- Efficacy and safety of insulin analogues for the management of diabetes mellitus: a meta-analysisCMAJ : Canadian Medical Association Journal, 2009
- Insulin analogues display IGF‐I‐like mitogenic and anti‐apoptotic activities in cultured cancer cellsDiabetes/Metabolism Research and Reviews, 2009
- Proliferative effects of insulin analogues on mammary epithelial cellsArchives of Physiology and Biochemistry, 2008
- Long-acting insulin analogues versus NPH insulin (human isophane insulin) for type 2 diabetes mellitusCochrane Database of Systematic Reviews, 2007
- Diabetes mellitus and risk of breast cancer: A meta‐analysisInternational Journal of Cancer, 2007
- Diabetes Mellitus and Risk of Colorectal Cancer: A Meta-AnalysisJNCI Journal of the National Cancer Institute, 2005
- Metformin and reduced risk of cancer in diabetic patientsBMJ, 2005
- Insulin, Insulin-Like Growth Factor-I (IGF-I), IGF Binding Proteins, Their Biologic Interactions, and Colorectal CancerJNCI Journal of the National Cancer Institute, 2002
- Evaluation of the Carcinogenic Potential of Insulin Glargine (LANTUS) in Rats and MiceInternational Journal of Toxicology, 2002
- The bioactivity of insulin analogues from in vitro receptor binding to in vivo glucose uptakeDiabetes/Metabolism Research and Reviews, 1992